Cyclin D1 Antikörper (AA 1-233) (FITC)

Produktnummer ABIN7145169

Produktdetails anti-Cyclin D1 Antikörper (FITC)

Target: Cyclin D1 (CCND1)

Bindungsspezifität: AA 1-233

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Cyclin D1 Antikörper ist konjugiert mit FITC

Applikation: Bitte anfragen

Kreuzreaktivität: Human

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human B-cell lymphoma/leukemia 10 protein (1-233AA)

Isotyp: IgG

Anwendungsinformationen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu Cyclin D1

Target: Cyclin D1 (CCND1)

Andere Bezeichnung: BCL1 (CCND1 Produkte)

Synonyme: BCL1 antikoerper, D11S287E antikoerper, PRAD1 antikoerper, U21B31 antikoerper, AI327039 antikoerper, CycD1 antikoerper, Cyl-1 antikoerper, bcl-1 antikoerper, cD1 antikoerper, cb161 antikoerper, cycd1 antikoerper, etID37810.7 antikoerper, fb52e01 antikoerper, fc45c08 antikoerper, fc83a12 antikoerper, id:ibd1198 antikoerper, wu:fb52e01 antikoerper, wu:fc45c08 antikoerper, wu:fc83a12 antikoerper, ccnd1b antikoerper, prad1 antikoerper, ccnd1 antikoerper, ccnd1a antikoerper, bcl1 antikoerper, d11s287e antikoerper, u21b31 antikoerper, CCND1 antikoerper, cyclin D1 antikoerper, cyclin D1 S homeolog antikoerper, cyclin D1 L homeolog antikoerper, CCND1 antikoerper, Ccnd1 antikoerper, ccnd1 antikoerper, ccnd1.S antikoerper, ccnd1.L antikoerper

Hintergrund:

Background: Promotes apoptosis, pro-caspase-9 maturation and activation of NF-kappa-B via NIK and IKK. May be an adapter protein between upstream TNFR1-TRADD-RIP complex and the downstream NIK-IKK-IKAP complex. Is a substrate for MALT1.

Aliases: AI132454 antibody, B cell CLL/lymphoma 10 antibody, B cell lymphoma/leukemia10 antibody, B-cell CLL/lymphoma 10 antibody, B-cell leukemia/lymphoma 10 antibody, B-cell lymphoma/leukemia 10 antibody, Bcl 10 antibody, Bcl-10 antibody, Bcl10 antibody, BCL10_HUMAN antibody, c E10 antibody, c-E10 antibody, C81403 antibody, CARD containing apoptotic signaling protein antibody, CARD containing molecule enhancing NF kappa B antibody, CARD containing molecule enhancing NF kB antibody, CARD containing molecule enhancing NF-kB antibody, CARD containing molecule enhancing NFkB antibody, CARD containing proapoptotic protein antibody, CARD like apoptotic protein antibody, CARD-containing apoptotic signaling protein antibody, CARD-containing molecule enhancing NF-kappa-B antibody, CARD-containing proapoptotic protein antibody, CARD-like apoptotic protein antibody, CARMEN antibody, Caspase recruiting domain containing protein antibody, caspase-recruiting domain-containing protein antibody, cCARMEN antibody, cE 10 antibody, cE10 antibody, CED 3/ICH 1 prodomain homologous E10 like regulator antibody, CED-3/ICH-1 prodomain homologous E10-like regulator antibody, CED3/ICH1 prodomain homologous E10 like regulator antibody, Cellular E10 antibody, Cellular homolog of vCARMEN antibody, Cellular-E10 antibody, CIPER antibody, CLAP antibody, hCLAP antibody, Mammalian CARD containing adapter molecule E10 antibody, Mammalian CARD-containing adapter molecule E10 antibody, mE 10 antibody, mE10 antibody, R-RCD1 antibody

UniProt: O95999

Pathways: PI3K-Akt Signalweg, Zellzyklus, Mitotic G1-G1/S Phases, ER-Nucleus Signaling